Qvin Stock

Founded in 2014, Qvin stands at the intersection of healthcare innovation and women’s wellness, redefining how menstrual blood is used for diagnostic purposes. The idea was born from the realization that menstrual blood, traditionally considered waste, holds significant diagnostic potential which could transform women's health monitoring. Qvin’s primary product, the Q-Pad, is a scientifically developed menstrual pad designed for dual purposes: it functions as a regular menstrual pad while also acting as a collection device for menstrual blood, which can be used to test for health indicators. This product is the first of its kind to be cleared by the FDA for this use. It works on a simple principle: users wear the pad, and then send it to Qvin's lab, where the collected samples are analyzed for various health biomarkers. The company currently offers analysis for biomarkers such as HbA1C, with plans to expand to others like TSH (Thyroid-Stimulating Hormone), CRP (C-Reactive Protein), and markers relevant to fertility and menstrual health such as AMH, FSH, and LH. The process is needle-free and non-invasive, making it an appealing option for those who prefer a gentler approach to health monitoring. Qvin was co-founded by Sara Naseri and a team motivated by the potential to leverage a natural biological process to aid in health diagnostics. They aim to empower menstruating individuals by providing them with data that could influence their health decisions. Located in the heart of Silicon Valley, Qvin has carved a niche for itself by merging biotechnology with consumer health products, thus fostering an innovative approach to women's health. The company also actively participates in medical research to further the understanding of female biology, which has historically been underrepresented in medical studies. By offering the Q-Pad, Qvin not only provides a health monitoring product but also invites its users to participate in a larger movement aimed at improving healthcare for women worldwide. This revolutionary approach positions Qvin at the forefront of personalized health technology and women’s health advocacy.